共 50 条
Epigenetic mechanisms as a new approach in cancer treatment: An updated review
被引:150
|作者:
Fardi, Masoumeh
[1
,4
]
Solali, Saeed
[2
,3
]
Hagh, Majid Farshdousti
[5
]
机构:
[1] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Mol Med Res Ctr, Tabriz, Iran
[3] Tabriz Univ Med Sci, Hematol & Oncol Res Ctr, Tabriz, Iran
[4] Tabriz Univ Med Sci, Div Hematol & Blood Transfus Med, Dept Immunol, Tabriz, Iran
[5] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
关键词:
Cancer;
Epigenetic;
Mechanisms;
Treatment;
Methylation;
DNA METHYLATION INHIBITORS;
PROMOTER METHYLATION;
DNMT3A MUTATIONS;
SOLID TUMORS;
DEMETHYLATION;
EXPRESSION;
CHROMATIN;
GENES;
EZH2;
HYPERMETHYLATION;
D O I:
10.1016/j.gendis.2018.06.003
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Epigenetic, along with genetic mechanisms, is essential for natural evolution and maintenance of specific patterns of gene expression in mammalians. Global epigenetic variation is inherited somatically and unlike genetic variation, it is dynamic and reversible. They are somatically associated with known genetic variations. Recent studies indicate the broad role of epigenetic mechanisms in the initiation and development of cancers, that they are including DNA methylation, histone modifications, nucleosomes changes, non-coding RNAs. The reversible nature of epigenetic changes has led to the emergence of novel epigenetic therapeutic approaches, so that several types of these medications have been approved by the FDA so far. In this review, we discuss the concept of epigenetic changes in diseases, especially cancers, the role of these changes in the onset and progression of cancers and the potential of using this knowledge in designing novel therapeutic strategies. Copyright (C) 2018, Chongqing Medical University. Production and hosting by Elsevier B.V.
引用
收藏
页码:304 / 311
页数:8
相关论文